Expanded Access Use of Recombinant Bacillus Calmette-Guerin in Non-muscle Invasive Bladder Cancer

To provide an expanded access protocol designed to provide rMBCG to patients with non-muscle invasive bladder cancer (NMIBC) who are eligible to receive TICE BCG, may benefit from its use, & who are ineligible to participate in another clinical trial using rMBCG.

For more information please visit https://clinicaltrials.gov/study/NCT06810141

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .